The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Open accessAbstract
The technique of attaching the polymer polyethylene glycol (PEG), or PEGylation, has brought more than ten protein drugs into market. The surface conjugation of PEG on proteins prolongs their blood circulation time and reduces immunogenicity by increasing their hydrodynamic size and masking surface epitopes. Despite this success, an emerging body of literature highlights the presence of antibodies produced by the immune system that specifically recognize and bind to PEG (anti-PEG Abs), including both pre-existing and treatment-induced Abs. More importantly, the existence of anti-PEG Abs has been correlated with loss of therapeutic efficacy and increase in adverse effects in several clinical reports examining different PEGylated therapeutics. To better understand the nature of anti-PEG immunity, we summarize a number of clinical reports and some critical animal studies regarding pre-existing and treatment-induced anti-PEG Abs. Various anti-PEG detection methods used in different studies were provided. Several protein modification technologies beyond PEGylation were also highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Jiang, S., & Cao, Z. (2010) · Advanced Materials · doi:10.1002/adma.200901407 · Cited by 2,027
Self-citationOvercoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Structural and immunologic characterization of bovine, horse, and rabbit serum albumins
Majorek, K. A., Porebski, P. J., Dayal, A., Zimmerman, M. D., Jablonska, K., Stewart, A. J., Chruszcz, M., & Minor, W. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.05.011 · Cited by 971
Molecular Understanding and Design of Zwitterionic Materials
Shao, Q., & Jiang, S. (2015) · Advanced Materials · doi:10.1002/adma.201404059 · Cited by 908
Self-citationThe accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
PEG — A versatile conjugating ligand for drugs and drug delivery systems
Kolate, A., Baradia, D., Patil, S., Vhora, I., Kore, G., & Misra, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.046 · Cited by 648
FDA-approved poly(ethylene glycol)–protein conjugate drugs
Alconcel, S. N. S., Baas, A. S., & Maynard, H. D. (2011) · Polymer Chemistry · doi:10.1039/c1py00034a · Cited by 643
Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
Pelegri-O’Day, E. M., Lin, E.-W., & Maynard, H. D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504390x · Cited by 622
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Keefe, A. J., & Jiang, S. (2012) · Nature Chemistry · doi:10.1038/nchem.1213 · Cited by 576
Self-citationMoro, T., Takatori, Y., Ishihara, K., Konno, T., Takigawa, Y., Matsushita, T., Chung, U.-I., Nakamura, K., & Kawaguchi, H. (2004) · Nature Materials · doi:10.1038/nmat1233 · Cited by 572
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
García, K. P., Zarschler, K., Barbaro, L., Barreto, J. A., O'Malley, W., Spiccia, L., Stephan, H., & Graham, B. (2014) · Small · doi:10.1002/smll.201303540 · Cited by 519
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C.-W., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
Schlapschy, M., Binder, U., Borger, C., Theobald, I., Wachinger, K., Kisling, S., Haller, D., & Skerra, A. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt023 · Cited by 342
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 340
Zheng, J., Li, L., Tsao, H.-K., Sheng, Y.-J., Chen, S., & Jiang, S. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.059428 · Cited by 340
Self-citationUltra-low fouling peptide surfaces derived from natural amino acids
Chen, S., Cao, Z., & Jiang, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.001 · Cited by 335
Self-citationAccelerated clearance of PEGylated liposomes in rats after repeated injections
Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327
Sequence, Structure, and Function of Peptide Self-Assembled Monolayers
Nowinski, A. K., Sun, F., White, A. D., Keefe, A. J., & Jiang, S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3006868 · Cited by 326
Self-citationZhang, P., Sun, F., Tsao, C., Liu, S., Jain, P., Sinclair, A., Hung, H.-C., Bai, T., Wu, K., & Jiang, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512465112 · Cited by 316
Self-citationNonfouling Behavior of Polycarboxybetaine-Grafted Surfaces: Structural and Environmental Effects
Zhang, Z., Vaisocherová, H., Cheng, G., Yang, W., Xue, H., & Jiang, S. (2008) · Biomacromolecules · doi:10.1021/bm800407r · Cited by 303
Self-citationPEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Zheng, J., Li, L., Chen, S., & Jiang, S. (2004) · Langmuir · doi:10.1021/la036345n · Cited by 288
Self-citationRichter, A. W., & Åkerblom, E. (1983) · International Archives of Allergy and Immunology · doi:10.1159/000233309 · Cited by 282
Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 273
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Hershfield, M. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Jaggers, D. A., & Sundy, J. S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4500 · Cited by 266
Lipsky, P. E., Calabrese, L. H., Kavanaugh, A., Sundy, J. S., Wright, D., Wolfson, M., & Becker, M. A. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4497 · Cited by 266
Shankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
Avramis, V. I., & Panosyan, E. H. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00003 · Cited by 240
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
Sundy, J. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Rehrig, C. D., Huang, W., & Hershfield, M. S. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22403 · Cited by 221
Mima, Y., Hashimoto, Y., Shimizu, T., Kiwada, H., & Ishida, T. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00144 · Cited by 209
Role of the methoxy group in immune responses to mPEG-protein conjugates
Sherman, M. R., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Saifer, M. G. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200551b · Cited by 185
Sundy, J. S., Becker, M. A., Baraf, H. S. B., Barkhuizen, A., Moreland, L. W., Huang, W., Waltrip, R. W., Maroli, A. N., Horowitz, Z., & Pegloticase Phase 2 Study Investigators (2008) · Arthritis & Rheumatism · doi:10.1002/art.23810 · Cited by 181
Minimizing the immunogenicity of protein therapeutics
Chirino, A. J., Ary, M. L., & Marshall, S. A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02953-2 · Cited by 177
Protein–polymer conjugation — moving beyond PEGylation
Qi, Y., & Chilkoti, A. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.08.009 · Cited by 176
Longo, N., Harding, C. O., Burton, B. K., Grange, D. K., Vockley, J., Wasserstein, M., Rice, G. M., Dorenbaum, A., Neuenburg, J. K., Musson, D. G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61841-3 · Cited by 167
Shiraishi, K., Hamano, M., Ma, H., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., & Yokoyama, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.016 · Cited by 141
Poly(2-methacryloyloxyethyl phosphorylcholine) for Protein Conjugation
Lewis, A. L., Tang, Y., Brocchini, S., Choi, J.-W., & Godwin, A. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800242t · Cited by 134
Decoding nonspecific interactions from nature
White, A. D., Nowinski, A. K., Huang, W., Keefe, A. J., Sun, F., & Jiang, S. (2012) · Chemical Science · doi:10.1039/c2sc21135a · Cited by 127
Self-citationDextrin–rhEGF conjugates as bioresponsive nanomedicines for wound repair
Hardwicke, J., Ferguson, E. L., Moseley, R., Stephens, P., Thomas, D. W., & Duncan, R. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.023 · Cited by 123
Müller, H., Löning, L., Horn, A., Schwabe, D., Gunkel, M., Schrappe, M., von Schütz, V., Henze, G., da Palma, J. C., Ritter, J., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02187.x · Cited by 120
Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
Środa-Pomianek, K., Rydlewski, J., Langner, M., Kozubek, A., Grzybek, M., & Sikorski, A. F. (2005) · PubMed · Cited by 116
Saifer, M. G. P., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Sherman, M. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.014 · Cited by 112
Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response
Liu, S., & Jiang, S. (2016) · Nano Today · doi:10.1016/j.nantod.2016.05.006 · Cited by 112
Self-citationBranca, C., Magazù, S., Maisano, G., Migliardo, F., Migliardo, P., & Romeo, G. (2002) · The Journal of Physical Chemistry B · doi:10.1021/jp014345v · Cited by 97
Su, Y.-C., Chen, B., Chuang, K.-H., Cheng, T., & Roffler, S. R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100067t · Cited by 93
Liang, S., Liu, Y., Jin, X., Liu, G., Wen, J., Zhang, L., Li, J., Yuan, X., Chen, I. S. Y., Chen, W., et al. (2016) · Nano Research · doi:10.1007/s12274-016-0991-3 · Cited by 92
Shimizu, T., Mima, Y., Hashimoto, Y., Ukawa, M., Ando, H., Kiwada, H., & Ishida, T. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.005 · Cited by 91
Biologically Inspired Stealth Peptide-Capped Gold Nanoparticles
Nowinski, A. K., White, A. D., Keefe, A. J., & Jiang, S. (2014) · Langmuir · doi:10.1021/la404980g · Cited by 91
Self-citationImmunological Properties of Uricase Conjugated to Neutral Soluble Polymers
Caliceti, P., Schiavon, O., & Veronese, F. M. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000119x · Cited by 90
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor
Mero, A., Fang, Z., Pasut, G., Veronese, F. M., & Viegas, T. X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.025 · Cited by 80
PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol
Henriksen, L. T., Harila‐Saari, A. H., Ruud, E., Abrahamsson, J., Pruunsild, K., Vaitkevičienė, G. E., Jónsson, Ó. G., Schmiegelow, K., Heyman, M. M., Schrøder, H. D., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25319 · Cited by 80
Cleland, J. L., Geething, N. C., Moore, J. A., Rogers, B. C., Spink, B. J., Wang, C.-W., Alters, S. E., Stemmer, W. P. C., & Schellenberger, V. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23229 · Cited by 78
Tocoian, A., Buchan, P., Kirby, H., Soranson, J. A., Zamacona, M. K., Walley, R. J., Mitchell, N. E., Esfandiari, E., Wagner, F. D., & Oliver, R. (2015) · Lupus · doi:10.1177/0961203315574558 · Cited by 77
PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy
Morath, V., Bolze, F., Schlapschy, M., Schneider, S. E., Sedlmayer, F., Seyfarth, K., Klingenspor, M., & Skerra, A. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5007147 · Cited by 77
Anaphylaxis to macrogol 4000 after a parenteral corticoid injection
Dewachter, P., & Mouton‐Faivre, C. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00783.x · Cited by 76
Alters, S. E., McLaughlin, B., Spink, B. J., Lachinyan, T., Wang, C., Podust, V. N., Schellenberger, V., & Stemmer, W. P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050630 · Cited by 69
Xu, Y., Mehl, J. T., Bakhtiar, R., & Woolf, E. (2010) · Analytical Chemistry · doi:10.1021/ac1009832 · Cited by 64
Liu, Y., Reidler, H., Pan, J., Milunic, D., Qin, D., Chen, D., Vallejo, R. P., & Yin, R. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.07.003 · Cited by 64
Deng, Y., Wang, C., Cheng, X., Su, Y., Pei, Y., Song, Y., Jiao, J., Huang, Z., Ma, Y., Dong, Y., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82481 · Cited by 61
Geething, N. C., To, W., Spink, B. J., Scholle, M. D., Wang, C., Yin, Y., Yao, Y., Schellenberger, V., Cleland, J. L., Stemmer, W. P. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010175 · Cited by 61
Harari, D., Kuhn, N., Abramovich, R., Sasson, K., Zozulya, A. L., Smith, P. A., Schlapschy, M., Aharoni, R., Köster, M., Eilam, R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.602474 · Cited by 61
Vrooman, L. M., Kirov, I. I., Dreyer, Z. E., Kelly, M. E., Hijiya, N., Brown, P. A., Drachtman, R. A., Messinger, Y. H., Ritchey, A. K., Hale, G. A., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25757 · Cited by 57
Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response
Zhang, P., Jain, P. R., Tsao, C., Sinclair, A., Sun, F., Hung, H., Bai, T., Wu, K., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.008 · Cited by 44
Self-citationTillmann, H. L., Ganson, N. J., Patel, K., Thompson, A. J., Abdelmalek, M. F., Moody, T., McHutchison, J. G., & Hershfield, M. S. (2010) · Journal of Hepatology · doi:10.1016/s0168-8278(10)60309-1 · Cited by 37
Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies
Tung, H.-Y., Su, Y.-C., Chen, B., Burnouf, P., Huang, W.-C., Chuang, K.-H., Yan, Y.-T., Cheng, T., & Roffler, S. R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0151 · Cited by 34
White, J. T., Newsome, S. D., Kieseier, B. C., Bermel, R. A., Cui, Y., Seddighzadeh, A., Hung, S., Crossman, M., & Subramanyam, M. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616633967 · Cited by 29
Haeckel, A., Appler, F., Figge, L., Kratz, H., Lukas, M., Michel, R., Schnorr, J., Zille, M., Hamm, B. K., & Schellenberger, E. A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.128108 · Cited by 26
Figueiredo, L. M., Cole, P. D., & Drachtman, R. A. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1142370 · Cited by 23
Dong, H., Mora, J. R., Brockus, C. L., Chilewski, S. D., Dodge, R. W., Merrifield, C., Dickerson, W. M., & Desilva, B. S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9799-4 · Cited by 21
Smorodinsky, N. I., Specht, B.-U. V., Cesla, R., & Shaltiel, S. (1981) · Immunology Letters · doi:10.1016/0165-2478(81)90024-9 · Cited by 14
Generation and Characterization of a Monoclonal IgG Antibody to Polyethylene Glycol
Wunderlich, D. A., MacDougall, M. L., Mierz, D. V., Toth, J. G., Buckholz, T. M., Lumb, K. J., & Vasavada, H. A. (2007) · Hybridoma · doi:10.1089/hyb.2007.006 · Cited by 13
Ma, Y., Thota, B. N. S., Haag, R., & Budiša, N. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.055 · Cited by 7
Cited by
Polymer–drug conjugate therapeutics: advances, insights and prospects
Ekladious, I., Colson, Y. L., & Grinstaff, M. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0005-0 · Cited by 855
Hoang Thi, T. T., Pilkington, E. H., Nguyen, D. H., Lee, J. S., Park, K. D., & Truong, N. P. (2020) · Polymers · doi:10.3390/polym12020298 · Cited by 668
Unlocking the promise of mRNA therapeutics
Rohner, E., Yang, R., Foo, K. S., Goedel, A., & Chien, K. R. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01491-z · Cited by 612
Chen, B.-M., Cheng, T.-L., & Roffler, S. R. (2021) · ACS Nano · doi:10.1021/acsnano.1c05922 · Cited by 563
Biomaterial-based antimicrobial therapies for the treatment of bacterial infections
Kalelkar, P. P., Riddick, M., & García, A. J. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00362-4 · Cited by 548
Metadata
- Authors
- Zhang, P., Sun, F., Liu, S., & Jiang, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 244
- Issue
- Pt B
- Pages
- 184-193
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2472635460
- Cited by
- 688
- References
- 88
- FWCI
- 32.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.